276 related articles for article (PubMed ID: 1705008)
1. Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.
McWhirter JR; Wang JY
Mol Cell Biol; 1991 Mar; 11(3):1553-65. PubMed ID: 1705008
[TBL] [Abstract][Full Text] [Related]
2. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias.
McWhirter JR; Wang JY
EMBO J; 1993 Apr; 12(4):1533-46. PubMed ID: 8467803
[TBL] [Abstract][Full Text] [Related]
3. Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.
Pendergast AM; Muller AJ; Havlik MH; Clark R; McCormick F; Witte ON
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5927-31. PubMed ID: 1712111
[TBL] [Abstract][Full Text] [Related]
4. Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein.
McWhirter JR; Wang JY
Oncogene; 1997 Oct; 15(14):1625-34. PubMed ID: 9349495
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
[TBL] [Abstract][Full Text] [Related]
6. A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.
Muller AJ; Pendergast AM; Havlik MH; Puil L; Pawson T; Witte ON
Mol Cell Biol; 1992 Nov; 12(11):5087-93. PubMed ID: 1383690
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of P160 BCR by P210 BCR-ABL.
Lu D; Liu J; Campbell M; Guo JQ; Heisterkamp N; Groffen J; Canaani E; Arlinghaus R
Blood; 1993 Aug; 82(4):1257-63. PubMed ID: 8353288
[TBL] [Abstract][Full Text] [Related]
8. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins.
McWhirter JR; Galasso DL; Wang JY
Mol Cell Biol; 1993 Dec; 13(12):7587-95. PubMed ID: 8246975
[TBL] [Abstract][Full Text] [Related]
9. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein.
Liu J; Wu Y; Arlinghaus RB
Cancer Res; 1996 Nov; 56(22):5120-4. PubMed ID: 8912843
[TBL] [Abstract][Full Text] [Related]
10. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
11. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho.
Cicchetti P; Mayer BJ; Thiel G; Baltimore D
Science; 1992 Aug; 257(5071):803-6. PubMed ID: 1379745
[TBL] [Abstract][Full Text] [Related]
12. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON
Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
[TBL] [Abstract][Full Text] [Related]
14. An activating mutation in the ATP binding site of the ABL kinase domain.
Allen PB; Wiedemann LM
J Biol Chem; 1996 Aug; 271(32):19585-91. PubMed ID: 8702653
[TBL] [Abstract][Full Text] [Related]
15. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.
He Y; Wertheim JA; Xu L; Miller JP; Karnell FG; Choi JK; Ren R; Pear WS
Blood; 2002 Apr; 99(8):2957-68. PubMed ID: 11929787
[TBL] [Abstract][Full Text] [Related]
16. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
17. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
Muller AJ; Young JC; Pendergast AM; Pondel M; Landau NR; Littman DR; Witte ON
Mol Cell Biol; 1991 Apr; 11(4):1785-92. PubMed ID: 2005881
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
[TBL] [Abstract][Full Text] [Related]
19. Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway.
Bassermann F; Jahn T; Miething C; Seipel P; Bai RY; Coutinho S; Tybulewicz VL; Peschel C; Duyster J
J Biol Chem; 2002 Apr; 277(14):12437-45. PubMed ID: 11790798
[TBL] [Abstract][Full Text] [Related]
20. Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.
Arlinghaus RB
Oncogene; 2002 Dec; 21(56):8560-7. PubMed ID: 12476302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]